Cellnovo Group SA announced that its insulin cartridges are now refillable. This will enable people with insulin needs exceeding the current cartridge capacity to use the Cellnovo System, including some people with type 2 diabetes. Until now, patients using the Cellnovo System with daily insulin dose requirements over 50 units were obliged to use more than one cartridge every 3 days. This was leading to higher utilization costs and potentially limiting the adoption of the system by patients with higher insulin needs. They will now be able to refill the cartridge within three days of use and benefit from the quality of life offered by a miniaturized system, without any additional costs.